Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues.
Refusing Implantable Cardioverter Defibrillator (ICD) Replacement in Elderly Persons-The Same as Giving Up Life: A Qualitative Study.
Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, O'Donnell D, Knight BP, Clémenty N, Leclercq C, Amin A, Merkely BP, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Muñoz Carvajal I, Epstein LM, Sagi V, Johansen JB, Sterliński M, Steinwender C, Hounshell T, Abben R, Thompson AE, Wiggenhorn C, Willey S, Crozier I; Extravascular ICD Pivotal Study Investigators.
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
Subcutaneous implantable cardioverter-defibrillator therapy in Poland: Results of the Polish S-ICD Registry.
Kempa M, Budrejko S, Tajstra M, Syska P, Lewandowski M, Fabiszak T, Michalak M, Stanek A, Nowak K, Mitkowski P, Kaczmarek K, Orski Z, Janowski M, Szafarz P, Filipecki A, Sokal A, Szołkiewicz M, Jagielski D, Przybylski A.
Kardiol Pol. 2023;81(5):455-462. doi: 10.33963/KP.a2023.0046. Epub 2023 Mar 5.
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Stiles MK, Fauchier L, Morillo CA, Wilkoff BL; ESC Scientific Document Group.
Europace. 2019 Sep 1;21(9):1442-1443. doi: 10.1093/europace/euz065.
Benefit of Implantable Cardioverter-Defibrillator Generator Replacement in a Primary Prevention Population-Based Cohort.
Weng W, Sapp J, Doucette S, MacIntyre C, Gray C, Gardner M, Abdelwahab A, Parkash R.
JACC Clin Electrophysiol. 2017 Oct;3(10):1180-1189. doi: 10.1016/j.jacep.2017.03.004. Epub 2017 May 31.
Benefit of implantable cardioverter-defibrillator therapy after generator replacement in patients with Brugada syndrome.
Kim JY, Kim SH, Kim SS, Lee KH, Park HW, Cho JG, Uhm JS, Joung B, Pak HN, Lee MH, Park SJ, On YK, Kim JS, Lim HE, Shim J, Choi JI, Park SW, Kim YH, Lee WS, Kim J, Nam GB, Choi KJ, Kim YH, Oh YS, Lee MY, Rho TH.
Int J Cardiol. 2015;187:340-4. doi: 10.1016/j.ijcard.2015.03.262. Epub 2015 Mar 20.
Predictors of appropriate shock after generator replacement in patients with an implantable cardioverter defibrillator.
Arcinas LA, Chew DS, Seifer CM, Baranchuk A, Supel I, Exner DV, Boles U, McIntyre WF.
Pacing Clin Electrophysiol. 2021 May;44(5):911-918. doi: 10.1111/pace.14236. Epub 2021 Apr 16.
Estimating the Risks and Benefits of Implantable Cardioverter Defibrillator Generator Replacement: A Systematic Review.
Lewis KB, Stacey D, Carroll SL, Boland L, Sikora L, Birnie D.
Pacing Clin Electrophysiol. 2016 Jul;39(7):709-22. doi: 10.1111/pace.12850. Epub 2016 Apr 29.
Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ.
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):e003283. doi: 10.1161/CIRCEP.115.003283.
Clinical performance of implantable cardioverter-defibrillator lead monitoring diagnostics.
Poole JE, Swerdlow CD, Tarakji KG, Mittal S, Ellenbogen KA, Greenspon AJ, Kennergren C, Philbert BT, Moore J, Jones RC, Schaller RD, Hansalia R, Simmers T, Mihalcz A, DeBus B, Lexcen DR, Gunderson B, Wilkoff BL.
Heart Rhythm. 2022 Mar;19(3):363-371. doi: 10.1016/j.hrthm.2021.10.032. Epub 2021 Nov 9.
The Subcutaneous Implantable Cardioverter Defibrillator.
Mangels D, Frishman WH.
Cardiol Rev. 2016 Sep-Oct;24(5):248-55. doi: 10.1097/CRD.0000000000000099.
